MMP2 and diabetes mellitus: Therapeutic treatment with MMPI blocked diabetes-induced increase in plasma MMP2 and -9 activities by 2- and 1.2-fold, respectively (Figure 6f and g), confirming that this inhibitor reduces the activity of both MMPs in vivo.